Allogeneic Hematopoietic Stem Cell Transplantation with Clofarabine/Busulfan × 4 (CloBu4) Conditioning Exhibits Significant Anti-Tumor Activity In Non - Remission Hematologic Malignancies, Especially In AML
Publication
, Conference
Mineishi, S; Magenau, J; Tobai, H; Pawarode, A; Peres, EM; Reddy, P; Kitko, C; Choi, S; Erba, HP; Kujawski, L; Yanik, G; Ferrara, J; Levine, JE
Published in: Blood
November 19, 2010
Duke Scholars
Published In
Blood
DOI
EISSN
1528-0020
ISSN
0006-4971
Publication Date
November 19, 2010
Volume
116
Issue
21
Start / End Page
35 / 35
Publisher
American Society of Hematology
Related Subject Headings
- Immunology
- 3213 Paediatrics
- 3201 Cardiovascular medicine and haematology
- 3101 Biochemistry and cell biology
- 1114 Paediatrics and Reproductive Medicine
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Mineishi, S., Magenau, J., Tobai, H., Pawarode, A., Peres, E. M., Reddy, P., … Levine, J. E. (2010). Allogeneic Hematopoietic Stem Cell Transplantation with Clofarabine/Busulfan × 4 (CloBu4) Conditioning Exhibits Significant Anti-Tumor Activity In Non - Remission Hematologic Malignancies, Especially In AML. In Blood (Vol. 116, pp. 35–35). American Society of Hematology. https://doi.org/10.1182/blood.v116.21.35.35
Mineishi, Shin, John Magenau, Hiromi Tobai, Attaphol Pawarode, Edward M. Peres, Pavan Reddy, Carrie Kitko, et al. “Allogeneic Hematopoietic Stem Cell Transplantation with Clofarabine/Busulfan × 4 (CloBu4) Conditioning Exhibits Significant Anti-Tumor Activity In Non - Remission Hematologic Malignancies, Especially In AML.” In Blood, 116:35–35. American Society of Hematology, 2010. https://doi.org/10.1182/blood.v116.21.35.35.
Mineishi S, Magenau J, Tobai H, Pawarode A, Peres EM, Reddy P, et al. Allogeneic Hematopoietic Stem Cell Transplantation with Clofarabine/Busulfan × 4 (CloBu4) Conditioning Exhibits Significant Anti-Tumor Activity In Non - Remission Hematologic Malignancies, Especially In AML. In: Blood. American Society of Hematology; 2010. p. 35–35.
Mineishi, Shin, et al. “Allogeneic Hematopoietic Stem Cell Transplantation with Clofarabine/Busulfan × 4 (CloBu4) Conditioning Exhibits Significant Anti-Tumor Activity In Non - Remission Hematologic Malignancies, Especially In AML.” Blood, vol. 116, no. 21, American Society of Hematology, 2010, pp. 35–35. Crossref, doi:10.1182/blood.v116.21.35.35.
Mineishi S, Magenau J, Tobai H, Pawarode A, Peres EM, Reddy P, Kitko C, Choi S, Erba HP, Kujawski L, Yanik G, Ferrara J, Levine JE. Allogeneic Hematopoietic Stem Cell Transplantation with Clofarabine/Busulfan × 4 (CloBu4) Conditioning Exhibits Significant Anti-Tumor Activity In Non - Remission Hematologic Malignancies, Especially In AML. Blood. American Society of Hematology; 2010. p. 35–35.
Published In
Blood
DOI
EISSN
1528-0020
ISSN
0006-4971
Publication Date
November 19, 2010
Volume
116
Issue
21
Start / End Page
35 / 35
Publisher
American Society of Hematology
Related Subject Headings
- Immunology
- 3213 Paediatrics
- 3201 Cardiovascular medicine and haematology
- 3101 Biochemistry and cell biology
- 1114 Paediatrics and Reproductive Medicine
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology